Skip to main content

Annals of Hematology

Ausgabe 3/2022

Inhalt (33 Artikel)

ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies

  • Open Access
  • Review Article

Filippo Consonni, Eleonora Gambineri, Claudio Favre

Castleman disease and TAFRO syndrome

  • Review Article

Yasufumi Masaki, Kotaro Arita, Tomoyuki Sakai, Kazue Takai, Sadao Aoki, Hiroshi Kawabata

Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus

  • Open Access
  • Original Article

Larissa Henze, Christoph Buhl, Michael Sandherr, Oliver A. Cornely, Werner J. Heinz, Yascha Khodamoradi, Til Ramon Kiderlen, Philipp Koehler, Alrun Seidler, Rosanne Sprute, Martin Schmidt-Hieber, Marie von Lilienfeld-Toal

Hemophagocytosis, hyper-inflammatory responses, and multiple organ damages in COVID-19-associated hyperferritinemia

Guiying Dong, Jianbo Yu, Weibo Gao, Wei Guo, Jihong Zhu, Tianbing Wang

Modern management of iron overload in thalassemia major patients guided by MRI techniques: real-world data from a long-term cohort study

  • Original Article

Selen Bayraktaroglu, Nihal Karadas, Sebnem Onen, Deniz Yılmaz Karapinar, Yesim Aydinok

The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease

  • Open Access
  • Original Article

Denis Soulières, Jules Mercier-Ross, Caroline Fradette, Anna Rozova, Yu Chung Tsang, Fernando Tricta

Hydroxyurea and fetal hemoglobin effect on leg ulcers in patients with sickle cell disease

  • Original Article

Seda S. Tolu, Andrew Crouch, Jaeun Choi, Qi Gao, Moramaya Reyes-Gil, Ugochi Olivia Ogu, Giacomo Vinces, Caterina P. Minniti

Red cell ektacytometry in two patients with chronic hemolytic anemia and three new α-spectrin variants

  • Original Article

Joan-Lluis Vives-Corrons, Elena Krishnevskaya, Inés Hernández-Rodriguez, Salvador Payán-Pernia, Ángel F. Remacha Sevilla, Isabel Badell

Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes

  • Original Article

Amer M. Zeidan, Daniel J. DeAngelo, Jeanne Palmer, Christopher S. Seet, Martin S. Tallman, Xin Wei, Heather Raymon, Priya Sriraman, Stephan Kopytek, Jan Philipp Bewersdorf, Michael R. Burgess, Kristen Hege, Wendy Stock

Genetic diversity within leukemia-associated immunophenotype-defined subclones in AML

  • Open Access
  • Original Article

F. Tiso, T. N. Koorenhof-Scheele, E. Huys, J. H. A. Martens, A. O. de Graaf, B. A. van der Reijden, S. M. C. Langemeijer, F. W. M. B. Preijers, L. I. Kroeze, J. H. Jansen

Evaluating outcomes of adult patients with acute lymphoblastic leukemia and lymphoblastic lymphoma treated on the GMALL 07/2003 protocol

  • Original Article

Danielle Fredman, Yakir Moshe, Ofir Wolach, Gabriel Heering, Keren Shichrur, Idan Goldberg, Liron Hofstetter, Miriam Neaman, Tomer Scheib, Victoria Marcu-Malina, Abraham Avigdor, Avichai Shimoni, Arnon Nagler, Jonathan Canaani

Optimization of high-dose methotrexate prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma: a multicenter analysis

  • Original Article

Yu Fang, Ning Su, Shuyun Ma, Jun Cai, Liye Zhong, Wenyu Li, Huiqiang Huang, Zhiming Li, He Huang, Yi Xia, Panpan Liu, Linlang Guo, Zhihua Li, Yudan Wu, Xiaopeng Tian, Jinni Wang, Yuchen Zhang, Qingqing Cai

First-line high-dose therapy and autologous blood stem cell transplantation in patients with primary central nervous system non-Hodgkin lymphomas—a single-centre experience in 61 patients

  • Open Access
  • Original Article

T. Brezina, H. von Dewitz, T. Schroeder, S. Ullrich, K. Nachtkamp, G. Reifenberger, B. Malzkorn, M. Sabel, R. Haas, G. Kobbe

First report of successful treatment for hemoglobin Bristol-Alesha by hemopoietic stem cell transplantation

  • Original Article

Shanshan Li, Kai Chen, Can Huang, Na Zhang, Hui Jiang, Shayi Jiang

Elevated REG3α predicts refractory aGVHD in patients who received steroids-ruxolitinib as first-line therapy

  • Original Article

Jingjing Yang, Bo Peng, Lu Wang, Xin Li, Fei Li, Xiangshu Jin, Mingyu Jia, Lingmin Xu, Liping Dou, Daihong Liu

Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experience from an HBV endemic area

  • Original Article

Yibo Wu, Yi Chen, Panpan Zhu, Baodong Ye, Ying Lu, Jimin Shi, Yamin Tan, Yanmin Zhao, Jian Yu, Xiaoyu Lai, Jianping Lan, Ting Si, Lihong Ni, He Huang, Yi Luo

Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia

  • Original Article

Kaito Harada, Shohei Mizuno, Shingo Yano, Akiyoshi Takami, Hiroto Ishii, Kazuhiro Ikegame, Yuho Najima, Shinichi Kako, Takashi Ashida, Souichi Shiratori, Shuichi Ota, Makoto Onizuka, Kentaro Fukushima, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, Masamitsu Yanada

Busulfan–fludarabine- or treosulfan–fludarabine-based myeloablative conditioning for children with thalassemia major

  • Original Article

Roswitha Lüftinger, Natalia Zubarovskaya, Jacques-Emmanuel Galimard, Annamaria Cseh, Elisabeth Salzer, Franco Locatelli, Mattia Algeri, Akif Yesilipek, Josu de la Fuente, Antonella Isgrò, Amal Alseraihy, Emanuele Angelucci, Frans J. Smiers, Giorgia La La Nasa, Marco Zecca, Tunc Fisgin, Emel Unal, Katharina Kleinschmidt, Christina Peters, Arjan Lankester, Selim Corbacioglu

Correlation of nutrition-associated parameters with non-relapse mortality in allogeneic hematopoietic stem cell transplantation

  • Open Access
  • Original Article

Judith Schaffrath, Tanja Diederichs, Susanne Unverzagt, Maxi Wass, Ulrike Gläser, Thomas Weber, Mascha Binder, Carsten Müller-Tidow, Lutz P. Müller

Hepatic sinusoidal obstruction syndrome post-chemotherapy in pediatric and adolescent age: case series of six patients in Qatar

  • Letter to the Editor

Tayseer AlSaad, Tayseer Yousif, Ayman Saleh, Hinda Ahmed, Catherine Cole, Chiara Cugno

Venetoclax and decitabine in refractory TP53-mutated early T-cell precursor acute lymphoblastic leukemia

  • Letter to the Editor

Jinyu Kong, Nan Chen, Mengyun Li, Jian Zhang, Xiaoxia Wu, Lihong Zong, Depei Wu, Baoquan Song, Huiying Qiu

A new case of Bicêtre hemoglobin in an adult male: clinical observations over a period of four years

  • Letter to the Editor

Giovanna Farfán-Quiroga, Maria del Mar Hermosilla-Fernandez, Jesus Feliu-Sanchez, Maria Jose Nájera-Irazu, Ricardo García-Muñoz

Successful treatment of hairy cell leukemia variant with obinutuzumab

  • Open Access
  • Letter to the Editor

Diana Al-Sarayfi, Freek O. Meeuwes, Thijs Oude Munnink, Wouter Plattel, Stefano Rosati, Estella Matutes, Marcel Nijland

Next-generation sequencing redefines the diagnosis of triple-negative myeloproliferative neoplasms

  • Letter to the Editor

Sanyun Wu, Ping Luo, Yalan Yu, Bei Xiong, Yingying Wang, Xuelan Zuo

Liquid biopsies of plasma and cerebrospinal fluid are useful for detection of intravascular lymphoma with central nervous system symptoms alone

  • Letter to the Editor

Hiroki Hosoi, Ikuro Tanigawa, Hideki Kosako, Akinao Okamoto, Ryuta Iwamoto, Jinsoo Koh, Megumi Mori, Takayuki Hiroi, Toshiki Mushino, Shogo Murata, Shinobu Tamura, Shin-Ichi Murata, Akihiro Tomita, Takashi Sonoki

Reduced bendamustine for elderly patients with follicular lymphoma

  • Letter to the Editor

Yosuke Masamoto, Arika Shimura, Mineo Kurokawa

Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine

  • Open Access
  • COVID-19
  • Letter to the Editor

Johannes Ruhe, Ulf Schnetzke, Karim Kentouche, Florian Prims, Michael Baier, Konstantin Herfurth, Mandy Schlosser, Martin Busch, Andreas Hochhaus, Gunter Wolf

Aggressive NK-cell leukemia with hemophagocytosis in a Caucasian patient

  • Letter to the Editor

Simon Michaelis, Angelika Pichler, Ingeborg Stelzer, Laurenz Schöffmann, Christoph Tinchon, Dietmar Enko

Successful ibrutinib treatment for central nervous system relapse of chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation

  • Letter to the Editor

Tomohiko Tanigawa, Masatoshi Sakurai, Jun Kato, Kota Mizuno, Shinya Fujita, Yuya Koda, Taku Kikuchi, Takayuki Shimizu, Shinichiro Okamoto, Keisuke Kataoka

TTP or complement-mediated TMA or both? A rare diagnosis and report of a novel plasminogen gene variant

  • Letter to the Editor

Nishant R. Tiwari, Sankalp Arora, Aditya G. Tolat, Saad Paul Shaheen II, Vivek R. Sharma

The added value of digital morphological analysis in the evaluation of peripheral blood films: the report of an UKNEQAS external quality assessment sample

  • Letter to the Editor

Marco Rosetti, Barbara De la Salle, Giorgia Farneti, Alice Clementoni, Giovanni Poletti, Romolo M. Dorizzi

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Metastasiertes CRC: besser Checkpointhemmer im Doppelpack!

Die Kombination von Nivolumab plus Ipilimumab ist beim metastasierten Kolorektalkarzinom mit MSI-H- oder dMMR klar im Vorteil gegenüber einer Nivolumab-Monotherapie: Das Progressionsrisiko war damit in einer Phase-3-Studie um 38% reduziert.

Riesenzellarteriitis: bilaterale Biopsie der Temporalarterien von Vorteil

Die Riesenzellarteriitis (RZA) erfordert eine rasche und präzise Diagnose, da innerhalb weniger Tage ein schwerer, irreversibler Sehverlust drohen kann. In diesem Zusammenhang scheint die bilaterale Biopsie der Temporalarterien (TAB) der unilateralen überlegen zu sein.

Große Trinkmengen bei Blasentumoren möglicherweise von Nachteil

Beim nicht-muskelinvasiven Blasenkrebs scheint eine hohe Flüssigkeitszufuhr keinen schützenden Effekt in Bezug auf das Risiko eines Rezidivs oder einer Krankheitsprogression zu haben. Eine niederländische Studie legt sogar nahe, dass große Trinkmengen das Fortschreiten der Erkrankung begünstigen könnten.

Höhere Trefferquoten bei Brustkrebsscreening dank KI?

Künstliche Intelligenz unterstützt bei der Auswertung von Mammografie-Screenings und senkt somit den Arbeitsaufwand für Radiologen. Wie wirken sich diese Technologien auf die Trefferquote und die Falsch-positiv-Rate aus? Das hat jetzt eine Studie aus Schweden untersucht.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.